Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2019
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapiesSpencer C Wei, Nana-Ama A S Anang, Roshan Sharma, et al.Oncogene|March 11, 2023
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanomaGamze Kuser-Abali, Youfang Zhang, Pacman Szeto, et al.The British Journal of Dermatology|December 9, 2025
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanomaPeinan Zhao, Christopher Chew, Pacman Szeto, et al.British Journal of Cancer|May 20, 2017
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastasesSagun Parakh, John J Park, Shehara Mendis, et al.Molecular Cell|July 2, 2026
Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTPGamze Kuser-Abali, Fumihito Noguchi, Peinan Zhao, et al.Nature Communications|February 14, 2020
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanomaElena Galvani, Piyushkumar A Mundra, Sara Valpione, et al.EMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.Journal for Immunotherapy of Cancer|February 6, 2025
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesDavid R Gandara, Neeraj Agarwal, Shilpa Gupta, et al.Cancers|November 13, 2021
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade OutcomesRobert A Szczepaniak Sloane, Michael G White, Russell G Witt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.Pageof 6